| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
The Journal of Immunology, Vol 151, Issue 3 1245-1254, Copyright © 1993 by American Association of Immunologists
ARTICLES |
KM Gilbert and WO Weigle
Scripps Research Institute, Department of Immunology, La Jolla, CA 92037.
Human gamma-globulin (HGG)-specific Th1 cells exposed to HGG presented by chemically fixed spleen cells are blocked in G1a phase when challenged subsequently with HGG. The present study made use of the G1a blocker n-butyrate to further examine the relationship between tolerance induction and cell cycle progression. Th1 cells from primary cultures containing n-butyrate together with HGG and immunogenic, nonfixed APC lost their ability to proliferate or secrete IL-2 in HGG- stimulated secondary cultures. In contrast to their lack of responsiveness to secondary Ag challenge, Th1 cells exposed to n- butyrate and HGG proliferated normally in secondary cultures stimulated with IL-2. The suppressive effects of n-butyrate appear to require TCR occupation; Th1 cells exposed to n-butyrate in the absence of HGG did not lose their ability to proliferate in Ag-stimulated secondary cultures. In addition, although both HGG-presenting APC and IL-2 stimulate Th1 cell cycle progression into G1a, only HGG-presenting APC induced Th1 cell anergy in conjunction with n-butyrate. Unlike n- butyrate, drugs that blocked Th1 cell cycle progression in G0, G1b, or S/G2 phases did not inhibit subsequent Ag-specific proliferation by Th1 cells. Thus it appears that n-butyrate-induced G1a sequestration, in association with TCR occupancy, induces Th1 cell anergy.
This article has been cited by other articles:
|
|
 |
|
  Md. R. Amin, P. K. Dudeja, K. Ramaswamy, and J. Malakooti Involvement of Sp1 and Sp3 in differential regulation of human NHE3 promoter activity by sodium butyrate and IFN-{gamma}/TNF-{alpha} Am J Physiol Gastrointest Liver Physiol, July 1, 2007; 293(1): G374 - G382. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Zheng, S. L. Collins, M. A. Lutz, A. N. Allen, T. P. Kole, P. E. Zarek, and J. D. Powell A Role for Mammalian Target of Rapamycin in Regulating T Cell Activation versus Anergy J. Immunol., February 15, 2007; 178(4): 2163 - 2170. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. A. Rowell, L. Wang, W. W. Hancock, and A. D. Wells The Cyclin-Dependent Kinase Inhibitor p27kip1 Is Required for Transplantation Tolerance Induced by Costimulatory Blockade J. Immunol., October 15, 2006; 177(8): 5169 - 5176. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 F. Meylan, M. De Smedt, G. Leclercq, J. Plum, O. Leupin, S. Marguerat, and B. Conrad Negative thymocyte selection to HERV-K18 superantigens in humans Blood, June 1, 2005; 105(11): 4377 - 4382. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. A. Rowell, M. C. Walsh, and A. D. Wells Opposing Roles for the Cyclin-Dependent Kinase Inhibitor p27kip1 in the Control of CD4+ T Cell Proliferation and Effector Function J. Immunol., March 15, 2005; 174(6): 3359 - 3368. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. L. Piekarz, R. W. Robey, Z. Zhan, G. Kayastha, A. Sayah, A. H. Abdeldaim, S. Torrico, and S. E. Bates T-cell lymphoma as a model for the use of histone deacetylase inhibitors in cancer therapy: impact of depsipeptide on molecular markers, therapeutic targets, and mechanisms of resistance Blood, June 15, 2004; 103(12): 4636 - 4643. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Allen, Y. Zheng, L. Gardner, M. Safford, M. R. Horton, and J. D. Powell The Novel Cyclophilin Binding Compound, Sanglifehrin A, Disassociates G1 Cell Cycle Arrest from Tolerance Induction J. Immunol., April 15, 2004; 172(8): 4797 - 4803. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. R. Lawson, R. Baccala, J. Song, M. Croft, D. H. Kono, and A. N. Theofilopoulos Deficiency of the Cyclin Kinase Inhibitor p21(WAF-1/CIP-1) Promotes Apoptosis of Activated/Memory T Cells and Inhibits Spontaneous Systemic Autoimmunity J. Exp. Med., February 17, 2004; 199(4): 547 - 557. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Colombetti, F. Benigni, V. Basso, and A. Mondino Clonal Anergy Is Maintained Independently of T Cell Proliferation J. Immunol., December 1, 2002; 169(11): 6178 - 6186. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Diakos, E. E. Prieschl, M. Saemann, V. Novotny, G. Bohmig, R. Csonga, T. Baumruker, and G. J. Zlabinger Novel Mode of Interference with Nuclear Factor of Activated T-cells Regulation in T-cells by the Bacterial Metabolite n-Butyrate J. Biol. Chem., June 28, 2002; 277(27): 24243 - 24251. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. D. Lunemann, S. Waiczies, S. Ehrlich, U. Wendling, B. Seeger, T. Kamradt, and F. Zipp Death Ligand TRAIL Induces No Apoptosis but Inhibits Activation of Human (Auto)antigen-Specific T Cells J. Immunol., May 15, 2002; 168(10): 4881 - 4888. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. L. Vanasek, A. Khoruts, T. Zell, and D. L. Mueller Antagonistic Roles for CTLA-4 and the Mammalian Target of Rapamycin in the Regulation of Clonal Anergy: Enhanced Cell Cycle Progression Promotes Recall Antigen Responsiveness J. Immunol., November 15, 2001; 167(10): 5636 - 5644. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. K. Jackson, A. DeLoose, and K. M. Gilbert Induction of Anergy in Th1 Cells Associated with Increased Levels of Cyclin-Dependent Kinase Inhibitors p21Cip1 and p27Kip1 1 J. Immunol., January 15, 2001; 166(2): 952 - 958. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J-P Segain, D R. de la Bletiere, A Bourreille, V Leray, N Gervois, C Rosales, L Ferrier, C Bonnet, H M Blottiere, and J-P Galmiche Butyrate inhibits inflammatory responses through NFkappa B inhibition: implications for Crohn's disease Gut, September 1, 2000; 47(3): 397 - 403. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. M. Gilbert, R. Wahid, N. P. Fecher, J. P. Freeman, and E. K. Fifer Potential Clinical Use of Butyric Acid Derivatives to Induce Antigen-Specific T Cell Inactivation J. Pharmacol. Exp. Ther., September 1, 2000; 294(3): 1146 - 1153. [Abstract] [Full Text]
|
|
|
|
|
|
A. D. Wells, M. C. Walsh, D. Sankaran, and L. A. Turka T Cell Effector Function and Anergy Avoidance Are Quantitatively Linked to Cell Division J. Immunol., September 1, 2000; 165(5): 2432 - 2443. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. A. Frauwirth, M.-L. Alegre, and C. B. Thompson Induction of T Cell Anergy in the Absence of CTLA-4/B7 Interaction J. Immunol., March 15, 2000; 164(6): 2987 - 2993. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. E. Sutton, M. J. Reitsma, N. Uchida, and P. O. Brown Transduction of Human Progenitor Hematopoietic Stem Cells by Human Immunodeficiency Virus Type 1-Based Vectors Is Cell Cycle Dependent J. Virol., May 1, 1999; 73(5): 3649 - 3660. [Abstract] [Full Text]
|
|
|
|
|
|
J. D. Powell, C. G. Lerner, and R. H. Schwartz Inhibition of Cell Cycle Progression by Rapamycin Induces T Cell Clonal Anergy Even in the Presence of Costimulation J. Immunol., March 1, 1999; 162(5): 2775 - 2784. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. W. Cole, Y. D. Korin, J. L. Fahey, and J. A. Zack Norepinephrine Accelerates HIV Replication Via Protein Kinase A-Dependent Effects on Cytokine Production J. Immunol., July 15, 1998; 161(2): 610 - 616. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. D. Korin and J. A. Zack Progression to the G1b Phase of the Cell Cycle Is Required for Completion of Human Immunodeficiency Virus Type 1 Reverse Transcription in T Cells J. Virol., April 1, 1998; 72(4): 3161 - 3168. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
